Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (3)
Active Filters (3)
Clear All
1 - 12 of 36 Results
Sort by:
Best Match

Relevance of multiparametric screening to drug discovery efforts
This white paper explores the importance of multiparametric screening to drug discovery efforts

Illuminating the path to innovation: Revvity's high content screening services
This scientific poster presented at ELRIG Drug Discovery introduces Revvity's preclinical high content imaging services.

Automated microRNA purification with chemagic 360 instrument
Discover efficient microRNA purification using the chemagic 360 instrument. This application note shows the workflow for miRNA isolation, improving throughput and reliability in molecular biology research.

Limitations in metagenomics analysis: a roadblock to discoveries
In this infographic, we explore obstacles to metagenomics analysis and their influence on the field of metagenomics.

Pooled functional genomic screening solutions and services
Functional genomic screening has the potential to reshape drug discovery, enhance our understanding of biological systems, and revolutionize personalized medicine.

Applying functional genomics strategies to high-content phenotypic screening
Explore cutting-edge functional genomics and high-content phenotypic screening in drug discovery. Download our whitepaper to learn about innovative techniques, best practices, and strategies for leveraging high-content imaging methods like cell painting to advance your research. Unlock the potential of genomic profiling and morphological analysis for therapeutic interventions

Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.

Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy

Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.

Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity

CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.

wbs-leveraging-multiplatform-cell-based-screening-for-target-id
Learn about how to leverage multiplatform cell-based screening for target ID in this on-demand webinar.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.